Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.36 is 241% above its 3-year average of 0.11, around the middle of its 3-year range (0.00–0.68).
As of the fiscal period ended Tuesday, March 31, 2026. 103.35% above its 12-month average of 0.18.
Reported quarterly current ratio; no daily interpolation. Q4 FY2025 (2026-03-31): 0.36.
CURRENT RATIO
0.36
CURRENT RATIO AVG TTM
0.18
CURRENT RATIO AVG 3Y
0.03
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+103.35%
CURRENT VS 3Y AVG
+1008.29%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.46
median of 672 covered companies
CURRENT VS SECTOR MEDIAN
-89.58%
vs the sector median at left
Market Cap
$63.23M
Current Ratio
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$63.47M
Current Ratio
9.90
TTM Avg
11.46
3Y Avg
13.71
5Y Avg
15.39
Market Cap
$63.90M
Current Ratio
2.49
TTM Avg
2.38
3Y Avg
2.41
5Y Avg
2.71
Market Cap
$60.12M
Current Ratio
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $63.23M | 0.36 | 0.18 | 0.03 | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.23M | 10.98 | 17.43 | 9.10 | 12.08 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.47M | 9.90 | 11.46 | 13.71 | 15.39 |
| InterCure Ltd. (INCR)vs › | $63.14M | 1.48 | 1.60 | 1.69 | 1.84 |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.90M | 2.49 | 2.38 | 2.41 | 2.71 |
| Adicet Bio, Inc. (ACET)vs › | $60.92M | 6.71 | 8.38 | 9.61 | 10.03 |
| Gossamer Bio, Inc. (GOSS)vs › | $66.02M | 0.53 | 4.76 | 5.20 | 7.10 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.17M | 1.35 | 1.97 | 5.50 | 8.52 |
| PDS Biotechnology Corporation (PDSB)vs › | $60.12M | 0.57 | 2.81 | 4.44 | 7.47 |
| Cingulate Inc. (CING)vs › | $66.20M | 3.50 | 1.85 | 1.22 | 3.58 |
Current Ratio
0.36
Quick Ratio
0.27
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-03-31 | 0.36 |
| 2026-03-31 | 0.36 |
| 2025-09-30 | 0.04 |
| 2025-09-30 | 0.04 |
| 2025-06-30 | 0.25 |
| 2025-03-31 | 0.01 |
| 2024-12-31 | 0.05 |
| 2024-09-30 | 0.02 |
| 2024-06-30 | 0.05 |
| 2024-03-31 | 0.03 |
| 2023-12-31 | 0.05 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.68 |
